In Balb/c SCID mice 4T1-HER2 cells were injected s c to initiate

In Balb/c SCID mice 4T1-HER2 cells were injected s.c. to initiate tumor growth. 14 days this website later the mice were infected i.v. with 1 × 108 CFU of differently coated Lm-spa+. After 24 h mice were sacrificed and tumors, liver and spleen excised aseptically. Organs were homogenized and plated in serial dilutions. In tumor, liver and spleen no significant differences in the bacterial counts were detected between the uncoated and Trastuzumab coated Lm-spa+. (PDF 18 KB) References 1. Coley WB: The treatment of malignant tumors by repeated inoculations of erysipelas. With a report of ten original cases. Clin Orthop

Relat Res 1893,1991(262):3–11. 2. Agrawal N, Bettegowda C, Cheong I, Geschwind JF, Drake CG, Hipkiss EL, Tatsumi M, Dang LH, Diaz LA Jr, Pomper M, Abusedera M, Wahl RL, Kinzler KW, Zhou S, Huso DL, Vogelstein B: Bacteriolytic therapy can generate a potent immune response against experimental tumors. Proc Natl Acad Sci USA 2004,101(42):15172–15177.PubMedCrossRef

3. Lee CH, Wu CL, Tai YS, Shiau AL: Systemic administration of attenuated Salmonella choleraesuis in combination with cisplatin for cancer therapy. Mol Ther 2005,11(5):707–716.PubMedCrossRef 4. Cunningham C, Nemunaitis J: A phase I trial of genetically modified Salmonella typhimurium expressing cytosine deaminase (TAPET-CD, VNP20029) administered by intratumoral injection in combination with 5-fluorocytosine for patients with advanced or metastatic cancer. Protocol no: CL-017. Version: April 9, 2001. Hum Gene Ther 2001,12(12):1594–1596.PubMed 5. Lee CH, Wu CL, Shiau AL: Endostatin gene therapy MGCD0103 in vivo delivered by Salmonella Dimethyl sulfoxide choleraesuis in murine tumor models. J Gene Med 2004,6(12):1382–1393.PubMedCrossRef 6. Minton NP: Clostridia in cancer therapy. Nature reviews – Microbiology 2003,1(December):237–242.PubMedCrossRef 7. Yazawa K, Fujimori M, Nakamura T, Sasaki T, Amano J, Kano Y, Taniguchi S: Bifidobacterium longum as a delivery system for gene therapy of chemically induced

rat mammary tumors. Breast Cancer Res Treat 2001,66(2):165–170.PubMedCrossRef 8. Yu YA, Shabahang S, Timiryasova TM, Zhang Q, Beltz R, Gentschev I, Goebel W, Szalay AA: Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins. Nat Biotechnol 2004,22(3):313–320.PubMedCrossRef 9. Shahabi V, Reyes-Reyes M, Wallecha A, Rivera S, Paterson Y, Maciag P: Development of a Listeria monocytogenes based vaccine against prostate cancer. Cancer Immunol Immunother 2008,57(9):1301–1313.PubMedCrossRef 10. Kim SH, Castro F, Paterson Y, Gravekamp C: High efficacy of a Listeria-based vaccine against metastatic breast cancer reveals a dual mode of action. Cancer Res 2009,69(14):5860–5866.PubMedCrossRef 11. van Pijkeren JP, Morrissey D, Monk IR, Cronin M, Rajendran S, O’Sullivan GC, Gahan CG, Tangney M: A novel Listeria monocytogenes-based DNA delivery system for cancer gene therapy. Hum Gene Ther 2010,21(4):405–416.PubMedCrossRef 12.

Comments are closed.